Search
Generic filters
Search in excerpt

Press release

Syvac® EH Marker is now marketed under the name ORBYK EHD

Call for applications now open · 29th edition · Syva Award International 2026

Syvazul® BTV 3 receives EMA authorization for cattle

CVMP grants Positive opinion for Syvazul® BTV3 for Europe

VMD grants marketing authorisation for Syvazul® BTV3 in Great Britain

28th edition of the Syva Award International – The laureates have been announced!

Syva Award International 2025 applications are now Closed

Syvazul® BTV3 to receive emergency use authorization in France

Syvac® EH Marker, the first and only DIVA vaccine against EHD, is now authorized in Belgium

Syva receives a positive opinion for Syvazul BTV 3 vaccine from the CVMP of the European Medicines Agency (EMA).

Syvac® EH Marker: the first and unique DIVA vaccine against EHD

The DGAV, authorized SYVAZUL BTV3, Syva’s vaccine against bluetongue serotype 3.

Vaccination against Bluetongue serotype 3 has started in Spain with Syvazul BTV3